Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 509 of 1,261

  1. US 10239870

    Dopamine D3 receptor antagonists

    Indivior UK Limited · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  2. US 10239867

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  3. US 10239830

    Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders

    The United States of America, as represented by the Secretary, Depart. of Health and Human Services · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  4. US 10238750

    Porphyrin modified telodendrimers

    The Regents of the University of California · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  5. US 10238749

    Angiotensinogen (AGT) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  6. US 10238735

    Controlled activation of complement components for use as endogenous adjuvant

    PLS-Design GmbH · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  7. US 10238734

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    The Regents of the University of California · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  8. US 10238674

    Bovine milk oligosaccharides

    The Regents of the University of California · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  9. US 10238659

    Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  10. US 10238655

    Dihydroindene and tetrahydronaphthalene compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  11. US 10238626

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  12. US 10238642

    Methods for treating neurogenic orthostatic hypotension

    Theravance Biopharma R&D IP, LLC · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  13. US 10238646

    Methods for treating pruritus

    Trevi Therapeutics, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  14. US 10238605

    Dry coated tablet

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  15. US 10238599

    Composition and method for treating congenital cytomegalovirus induced hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  16. US 10238606

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  17. US 10238618

    Compositions and methods for diagnosis and treatment of anemia

    United States of America as represented by the Secretary of the Air Force · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  18. AU 2017305856

    Pharmaceutical formulations of C1 esterase inhibitor

    CSL BEHRING GMBH [DE] · Granted Mar 21, 2019 · Expires Mar 16, 2039

    granted

  19. US 10232030

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  20. US 10232049

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  21. US 10233152

    LSD1 inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  22. US 10233209

    Inhibitors of the farnesoid x receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  23. US 10233244

    Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  24. US 10233452

    Compositions and methods for increasing erythropoietin (EPO) production

    Alnylam Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.